MedPath

SONEXA THERAPEUTICS, INC.

SONEXA THERAPEUTICS, INC. logo
🇺🇸United States
Ownership
Private
Established
2007-01-01
Employees
11
Market Cap
-
Website
http://sonexa.com

A Pilot Efficacy and Safety Study of ST101 in Essential Tremor

Phase 2
Completed
Conditions
Essential Tremor
Interventions
Drug: Placebo
First Posted Date
2011-04-11
Last Posted Date
2012-01-06
Lead Sponsor
Sonexa Therapeutics, Inc.
Target Recruit Count
25
Registration Number
NCT01332695

Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

Phase 2
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: Placebo
First Posted Date
2009-02-12
Last Posted Date
2012-06-07
Lead Sponsor
Sonexa Therapeutics, Inc.
Target Recruit Count
168
Registration Number
NCT00842673

Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease

Phase 2
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: Placebo
First Posted Date
2009-02-12
Last Posted Date
2012-06-07
Lead Sponsor
Sonexa Therapeutics, Inc.
Target Recruit Count
210
Registration Number
NCT00842816
© Copyright 2025. All Rights Reserved by MedPath